Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)

CUSIP: 98943L107

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
-12,802,365
SEC-reported price per share
$1.35
Indexed holders
85
Value change
-$20,028,376
Number of buys
32
Number of sells
47
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
97,315,887

Security key

98943L107

Report period

Q4 2025

Indexed institutions

85

Top holders

10

Ownership snapshot

Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
William Thurman Walters
Disclosed value leader
Anthony Y. Sun
Comparable rows
4/15
Latest evidence
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.9% 11 rows are not safely comparable across share classes. 13D/G row: William Thurman Walters Showing 1-6 of 15 holder rows.

Quick read

William Thurman Walters leads the comparable SEC ownership view at 9.9%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens William Thurman Walters's linked filing trail.
Comparable ownership Top 4
William Thurman Walters 9.9%
VANGUARD GROUP INC 4.6%
MILLENNIUM MANAGEMENT LLC 1.3%
FMR LLC 0.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
William Thurman Walters
13D/G
Walters William T
9.9%
Reported 13D/G · 29 Jan 2025
$10,081,500
7,050,000 shares
+$786,500 29 Jan 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
4.6%
Reported 13D/G · 31 Dec 2024
$4,677,873
3,271,240 shares
$0 31 Dec 2024
MILLENNIUM MANAGEMENT LLC
13F 13D/G
Company
1.3%
Reported 13D/G · 30 Sep 2025
$1,362,807
902,521 shares
— 30 Sep 2025
FMR LLC
13F 13D/G
Company
0.2%
Reported 13D/G · 29 Nov 2024
$306,990
203,305 shares
— 30 Sep 2025
Matrix Capital Management Company, LP
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$21,079,559
13,959,973 shares
— 30 Sep 2025
Anthony Y. Sun
3/4/5
President & CEO, Director
—
denominator unverified
$26,672,095
2,592,141 shares
— 04 Apr 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
85
Shares
40,517,312
Indexed holders
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
96
Q4 2025 indexed holders
85
Indexed holder difference
-11
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .